• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

2-Benzyloctahydro-1H-pyrrolo[3,4-c]pyridine Dihydrochloride (CAS 1187927-49-6): A Comprehensive Overview

2-Benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride (CAS 1187927-49-6) is a specialized chemical compound that has garnered significant attention in pharmaceutical research and organic synthesis. This bicyclic amine derivative, featuring a benzyl-substituted pyrrolopyridine core, serves as a valuable building block for drug discovery and medicinal chemistry applications.

The molecular structure of 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine combines a saturated pyrrolidine ring fused with a piperidine moiety, creating a rigid scaffold that mimics natural alkaloids. The dihydrochloride salt form enhances its stability and solubility, making it particularly useful in biological studies. Researchers frequently explore this compound's potential as a pharmacophore in central nervous system (CNS) drug development, given its structural similarity to neurotransmitters.

Recent scientific literature highlights the growing interest in pyrrolopyridine derivatives for their diverse biological activities. The 2-benzyl substituted variant (CAS 1187927-49-6) has shown promise in preliminary studies targeting neurological pathways, though detailed pharmacological data remains proprietary among research institutions. Its unique three-dimensional configuration allows for selective interactions with various enzyme systems, sparking investigations into potential therapeutic applications.

From a synthetic chemistry perspective, 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride presents interesting challenges and opportunities. The saturated ring system offers conformational constraints that can improve drug-like properties, while the benzyl group provides a handle for further structural modifications. These characteristics align with current pharmaceutical industry trends favoring constrained heterocycles in lead optimization programs.

The compound's physicochemical properties contribute to its research utility. With moderate water solubility due to its dihydrochloride salt form and appropriate lipophilicity from the benzyl substituent, CAS 1187927-49-6 demonstrates favorable characteristics for preclinical development. These properties address common formulation challenges faced by medicinal chemists working with CNS-targeting compounds that must cross the blood-brain barrier.

Quality control specifications for 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride typically require high purity levels (>98%) confirmed by HPLC analysis, with strict limits on residual solvents and heavy metals. Analytical methods including NMR, mass spectrometry, and elemental analysis verify the compound's identity and purity, meeting the rigorous standards of pharmaceutical research applications.

In the context of current research trends, this compound intersects with several hot topics in drug discovery: the exploration of privileged structures in medicinal chemistry, the development of neuromodulators with improved selectivity profiles, and the design of conformationally restricted analogs to enhance pharmacological properties. These connections make CAS 1187927-49-6 particularly relevant to contemporary pharmaceutical innovation.

Handling and storage recommendations for 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride follow standard laboratory protocols for amine salts: protection from moisture at controlled room temperature, with consideration given to its hygroscopic nature. Proper containment and ventilation practices ensure safe laboratory use while maintaining compound integrity.

The commercial availability of 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride from specialized chemical suppliers has expanded in recent years, reflecting growing research demand. Current market analysis indicates steady interest from both academic and industrial research sectors, particularly among organizations focusing on neuropharmacology and GPCR-targeted drug discovery programs.

Future research directions for this compound class may explore its potential in developing next-generation therapeutics for neurological conditions, building upon the structural advantages of the pyrrolopyridine scaffold. The benzyl substitution pattern offers opportunities for structure-activity relationship studies that could yield compounds with optimized pharmacological profiles.

From a regulatory perspective, CAS 1187927-49-6 currently falls outside controlled substance categories, making it accessible for legitimate research purposes. However, researchers should consult current regulations as chemical control policies continue to evolve in different jurisdictions.

The synthesis of 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride typically involves multi-step organic transformations starting from commercially available pyrrolidine or pyridine precursors. Key steps often include ring-forming reactions, hydrogenation to achieve the saturated system, and final benzylation followed by salt formation. Process chemists continue to refine these synthetic routes to improve yields and scalability.

In analytical applications, this compound serves as a valuable reference standard and building block. Its well-defined structure and purity make it suitable for method development in chromatographic techniques and spectroscopic analyses, particularly in studies of nitrogen-containing heterocycles that represent an important class of pharmaceutical ingredients.

The intellectual property landscape surrounding pyrrolopyridine derivatives remains active, with numerous patents filed for related structures in therapeutic applications. While CAS 1187927-49-6 itself may not be patented, derivative compounds incorporating this core structure frequently appear in patent literature, particularly in claims related to neurological disorders and psychiatric conditions.

Environmental and safety assessments of 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride indicate standard laboratory handling precautions are sufficient for research use. Material safety data sheets provide detailed guidance on personal protective equipment, spill response procedures, and waste disposal methods appropriate for this chemical class.

As research into nitrogen-containing heterocycles advances, 2-benzyloctahydro-1H-pyrrolo[3,4-c]pyridine dihydrochloride continues to demonstrate its value as a versatile intermediate. Its balanced physicochemical properties and structural features position it as an important tool for medicinal chemists addressing current challenges in drug discovery and pharmaceutical development.

• 64304-23-0(3,7-Diazabicyclo[3.3.1]nonane,3,7-bis(phenylmethyl)-, hydrochloride (1:1))
• 351370-98-4(2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine)
• 91189-26-3(2,7-Diazaspiro[4.4]nonane, 2-methyl-7-(phenylmethyl)-, dihydrochloride)
• 1086395-71-2(2-Benzyl-2,7-diazaspiro[4.5]decane)
• 1086395-18-7(7-benzyl-2,7-diazaspiro[4.5]decane)
• 920531-65-3(2-Benzyl-2,7-Diazaspiro4.4Nonane 2HCl)
• 128243-95-8(2,7-Diazaspiro[4.4]nonane,2,7-bis(phenylMethyl)-, (Hydrochloride) (1:2) (or 2,7-Diazaspiro[4.4]nonane,2,7-bis(phenylMethyl)-, (dihydrochloride) (9CI)))
• 91189-30-9(2,7-Diazaspiro[4.4]nonane, 2-ethyl-7-(phenylmethyl)-, dihydrochloride)
• 186203-32-7(5-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine)
• 64304-22-9(3,7-Diazabicyclo[3.3.1]nonane,3-butyl-7-(phenylmethyl)-, hydrochloride (1:1))